more_reports

The Latest Healthcare Services Articles from Streetwise Reports

Healthcare AI Company Rebrands as Rocket Doctor AI to Pursue Growing Market Opportunities

  ()
Treatment.com AI Inc. has rebranded and reincorporated as Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) to reflect the integration of its proprietary AI-driven Global Library of Medicine (GLM) with the recently acquired Rocket Doctor Inc. Read why one analyst calls part of the company's offerings "Shopify for physicians."
Tags: Healthcare ServicesTechnology

AI-Powered Medical Education Suite Cuts Costs, whilst Enhancing Clinical Skills Training for Future Doctors

  ()
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launched its enhanced medical education suite in Minnesota, showing strong reliability and providing schools with up to 40% cost savings. Read on to find out how AI-simulated patients are reshaping medical education and enhancing clinical skills at scale.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Treatment.com AI's Rocket Doctor Expands US Reach and Drives New Growth Through Virtual ER Innovation

  ()
Treatment.com AI Inc.'s (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) virtual care subsidiary, Rocket Doctor, has expanded its core virtual care services into New York and California. Separately, its virtual ER program, designed to reduce unnecessary emergency room visits, continues to demonstrate a strong impact. Over a 12-month period between 2023 and 2024, Rocket Doctor reported an 88% year-over-year increase in revenue."
Tags: Healthcare Services

AI Study Tracks Unexpected Cognitive Gains in Vascular Dementia Trial

  ()
Hemostemix Inc.'s (HEM:TSXV; HMTXF:OTCQB; 2VF0:FSE) Phase 1 trial, in collaboration with Firefly Neuroscience Inc. (AIFF:NASDAQ), is evaluating ACP-01s impact on vascular dementia using AI-driven brain analysis. Early insights could reshape treatment approaches.
Tags: Healthcare Services

Canadian Healthcare Co. Showcases Stable FQ424

Research Report
  ()
Leede Financial Inc. raised its target price on CareRX Corp. (CRRX:TSX; CHHHF:OTCMKTS). Read on to see why one Leede analyst rates the stock as a Buy.
Tags: Biotechnology / PharmaceuticalsHealthcare Services

Showing Results: 1 to 5 of 5